Lloyd-Smith Malcolm

Avg. Two Year Performance

No purchase track record
(16%) Avg. Sale Return
(8%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return4%(< 1%)(6%)(5%)(16%)
Sale Success Rate11 of 2112 of 214 of 213 of 211 of 21
Drugs » Biotechnology

Chief Integration Officer:

Holdings: 42.34K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

SVP, Reg Affairs, Qual & Clin:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--